Oncolytics Biotech Stock Analysis
| ONC Stock | CAD 1.33 0.04 2.92% |
Oncolytics Biotech is overvalued with Real Value of 1.22 and Hype Value of 1.39. The main objective of Oncolytics Biotech stock analysis is to determine its intrinsic value, which is an estimate of what Oncolytics Biotech is worth, separate from its market price. There are two main types of Oncolytics Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Oncolytics Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Oncolytics Biotech's stock to identify patterns and trends that may indicate its future price movements.
The Oncolytics Biotech stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Oncolytics Biotech is usually not traded on Canada Day, Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Oncolytics Stock trading window is adjusted to America/Toronto timezone.
Oncolytics |
Oncolytics Stock Analysis Notes
The company recorded a loss per share of 0.36. Oncolytics Biotech last dividend was issued on the 25th of May 2018. The entity had 105:1000 split on the 25th of May 2018. Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Oncolytics Biotech Inc. was founded in 1998 and is headquartered in Calgary, Canada. ONCOLYTICS BIOTECH operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. To find out more about Oncolytics Biotech contact Dr MBA at 403 670 7377 or learn more at https://www.oncolyticsbiotech.com.Oncolytics Biotech Investment Alerts
| Oncolytics Biotech had very high historical volatility over the last 90 days | |
| Oncolytics Biotech may become a speculative penny stock | |
| Net Loss for the year was (27.75 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Oncolytics Biotech has accumulated about 11.67 M in cash with (28.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.72. |
Oncolytics Largest EPS Surprises
Earnings surprises can significantly impact Oncolytics Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.11 | -0.09 | 0.02 | 18 | ||
2022-08-11 | 2022-06-30 | -0.11 | -0.09 | 0.02 | 18 | ||
2020-11-11 | 2020-09-30 | -0.14 | -0.16 | -0.02 | 14 |
Oncolytics Biotech Thematic Classifications
In addition to having Oncolytics Biotech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
Oncolytics Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 102.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oncolytics Biotech's market, we take the total number of its shares issued and multiply it by Oncolytics Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Oncolytics Profitablity
Oncolytics Biotech's profitability indicators refer to fundamental financial ratios that showcase Oncolytics Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, Oncolytics Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Oncolytics Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Oncolytics Biotech's profitability requires more research than a typical breakdown of Oncolytics Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.71) | (0.75) | |
| Return On Capital Employed | (0.98) | (1.03) | |
| Return On Assets | (0.71) | (0.75) | |
| Return On Equity | (1.01) | (0.96) |
Management Efficiency
Oncolytics Biotech has return on total asset (ROA) of (0.7133) % which means that it has lost $0.7133 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3822) %, meaning that it generated substantial loss on money invested by shareholders. Oncolytics Biotech's management efficiency ratios could be used to measure how well Oncolytics Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of November 2024, Return On Tangible Assets is likely to drop to -0.75. In addition to that, Return On Capital Employed is likely to drop to -1.03. At this time, Oncolytics Biotech's Other Current Assets are very stable compared to the past year. As of the 23rd of November 2024, Other Assets is likely to grow to 1.05, while Total Assets are likely to drop about 30.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.41 | 0.39 | |
| Tangible Book Value Per Share | 0.41 | 0.39 | |
| Enterprise Value Over EBITDA | (2.48) | (2.61) | |
| Price Book Value Ratio | 4.29 | 4.50 | |
| Enterprise Value Multiple | (2.48) | (2.61) | |
| Price Fair Value | 4.29 | 4.50 | |
| Enterprise Value | 83.7 M | 118 M |
Leadership effectiveness at Oncolytics Biotech is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Beta 1.506 | Return On Assets (0.71) | Return On Equity (1.38) |
Technical Drivers
As of the 23rd of November, Oncolytics Biotech holds the Semi Deviation of 3.09, risk adjusted performance of 0.0333, and Coefficient Of Variation of 3092.91. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncolytics Biotech, as well as the relationship between them.Oncolytics Biotech Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Oncolytics Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Oncolytics Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Oncolytics Biotech Outstanding Bonds
Oncolytics Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Oncolytics Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Oncolytics bonds can be classified according to their maturity, which is the date when Oncolytics Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Oncolytics Biotech Predictive Daily Indicators
Oncolytics Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oncolytics Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Oncolytics Biotech Forecast Models
Oncolytics Biotech's time-series forecasting models are one of many Oncolytics Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oncolytics Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Oncolytics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Oncolytics Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oncolytics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oncolytics Biotech. By using and applying Oncolytics Stock analysis, traders can create a robust methodology for identifying Oncolytics entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (6.74) | (7.08) | |
| Operating Profit Margin | (6.81) | (7.15) | |
| Net Loss | (6.75) | (7.08) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Oncolytics Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.